Status and phase
Conditions
Treatments
About
The goal of this clinical trial is to examine the use of sedative ketamine to treat depression and post-traumatic stress disorder (PTSD) in Veterans with mild to moderate traumatic brain injury (TBI). The main questions it aims to answer are:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Ketamine treatment within the last 6 months
Primary purpose
Allocation
Interventional model
Masking
40 participants in 2 patient groups
Loading...
Central trial contact
Paulo Shiroma, MD; Seth Dsiner, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal